{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fampridine-SR", "query": { "intervention": "Fampridine-SR" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fampridine-SR&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T13:35:13.590Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00041717", "title": "Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spinal Cord Injury", "Muscle Spasticity" ], "interventions": [ { "name": "Fampridine-SR", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Acorda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 213, "start_date": "2002-07", "completion_date": "2004-05", "has_results": true, "last_update_posted_date": "2020-01-14", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 37, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Palo Alto", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00041717" }, { "nct_id": "NCT00648908", "title": "Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Fampridine-SR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Acorda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 269, "start_date": "2006-06", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-02-27", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 27, "location_summary": "Phoenix, Arizona • Los Angeles, California • Sacramento, California + 24 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00648908" }, { "nct_id": "NCT07171203", "title": "Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gastrointestinal Stromal Tumors" ], "interventions": [ { "name": "Imatinib", "type": "DRUG" }, { "name": "Fampridine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2026-05-13", "completion_date": "2031-07", "has_results": false, "last_update_posted_date": "2026-05-27", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07171203" }, { "nct_id": "NCT00654927", "title": "Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Fampridine-SR b.i.d. (Twice Daily)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Acorda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 177, "start_date": "2003-11", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-03-02", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 20, "location_summary": "Phoenix, Arizona • Los Angeles, California • Atlanta, Georgia + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00654927" }, { "nct_id": "NCT01683838", "title": "Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spinal Cord Injury", "Muscle Spasticity" ], "interventions": [ { "name": "Fampridine-SR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Acorda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 204, "start_date": "2002-06", "completion_date": "2004-02", "has_results": true, "last_update_posted_date": "2017-08-25", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Long Beach, California • Sacramento, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Englewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01683838" }, { "nct_id": "NCT01328379", "title": "Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Dalfampridine-ER 5mg", "type": "DRUG" }, { "name": "Dalfampridine-ER 10mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Acorda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 430, "start_date": "2011-03", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2013-09-05", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 70, "location_summary": "Cullman, Alabama • Phoenix, Arizona • Sun City, Arizona + 59 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01328379" }, { "nct_id": "NCT01337986", "title": "Ampyra for Optic Neuritis in Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Multiple Sclerosis", "Optic Neuritis" ], "interventions": [ { "name": "Dalfampridine/Placebo", "type": "DRUG" }, { "name": "Placebo/Dalfampridine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 53, "start_date": "2011-05", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2020-01-30", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01337986" }, { "nct_id": "NCT00053417", "title": "Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)", "type": "DRUG" }, { "name": "15 mg fampridine-SR (4-aminopyridine, 4-AP)", "type": "DRUG" }, { "name": "20 mg fampridine-SR (4-aminopyridine, 4-AP)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Acorda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 206, "start_date": "2003-02", "completion_date": "2003-12", "has_results": true, "last_update_posted_date": "2011-08-04", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Los Angeles, California • New Haven, Connecticut + 19 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00053417" }, { "nct_id": "NCT02219932", "title": "Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "fampridine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 646, "start_date": "2014-09", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2017-03-27", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 17, "location_summary": "Cullman, Alabama • Phoenix, Arizona • San Diego, California + 12 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02219932" }, { "nct_id": "NCT00483652", "title": "Study of Fampridine-SR Tablets in Multiple Sclerosis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Fampridine-SR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Acorda Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 240, "start_date": "2007-05", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2016-02-04", "last_synced_at": "2026-09-03T13:35:13.590Z", "location_count": 36, "location_summary": "Phoenix, Arizona • Fayetteville, Arkansas • Berkeley, California + 31 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Berkeley", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00483652" } ] }